INTERACT2 was an international prospective , open-blinded end point , randomized controlled trial in 2839 patients with intracerebral hemorrhage ( < 6 hours ) with elevated systolic blood pressure randomly assigned to intensive ( target systolic blood pressure < 140 mm Hg ) or guideline-based ( systolic blood pressure < 180 mm Hg ) blood pressure management .